{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:09:18Z","timestamp":1791036558625,"version":"4.1.0"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Artemisinin combination therapies eliminate immature\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Plasmodium falciparum<\/jats:named-content>\n            gametocytes but not mature gametocytes, which may persist for up to 1 month posttreatment. A single dose of primaquine, which is inexpensive and effective against mature gametocytes, could be added to further reduce the potential for posttreatment parasite transmission. Currently, we have few data regarding the effectiveness or safety of doing so. We collected data from 21 therapeutic efficacy trials of the National Antimalarial Drug Resistance Monitoring System of India conducted during 2009 to 2010, wherein 9 sites used single-dose primaquine (0.75 mg\/kg of body weight) administered on day 2 along with artesunate plus sulfadoxine-pyrimethamine (AS+SP) while 12 did not. We estimated the effect of primaquine on posttreatment gametocyte clearance and the total number of gametocyte-weeks as determined by microscopy. We compared the median area under the curve for gametocyte density and reported adverse events. One thousand three hundred thirty-five patients completed the antimalarial drug treatment. Adjusting for region, primaquine increased the rate of gametocyte clearance (hazard ratio, 1.9; 95% confidence interval [CI], 1.1 to 3.3), prevented 45% (95% CI, 19 to 62) of posttreatment gametocyte-weeks, and decreased the area under the gametocyte density curve over the 28-day follow-up compared to AS+SP alone (\n            <jats:italic>P<\/jats:italic>\n            value = 0.01). The results were robust to other adjustment sets, and the estimated effect of primaquine increased during sensitivity analysis on the measurement of exposure time. No serious adverse events were detected. In conclusion, the addition of primaquine to AS+SP was effective in reducing the posttreatment presence of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">P. falciparum<\/jats:named-content>\n            gametocytes. Primaquine was well tolerated and could be administered along with an artemisinin combination therapy as the first-line therapy.\n          <\/jats:p>","DOI":"10.1128\/aac.00139-13","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T01:48:44Z","timestamp":1366076924000},"page":"2948-2954","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Nonrandomized Controlled Trial of Artesunate plus Sulfadoxine-Pyrimethamine with or without Primaquine for Preventing Posttreatment Circulation of Plasmodium falciparum Gametocytes"],"prefix":"10.1128","volume":"57","author":[{"given":"Naman K.","family":"Shah","sequence":"first","affiliation":[{"name":"School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA"},{"name":"Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA"},{"name":"National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Schapira","sequence":"additional","affiliation":[{"name":"Swiss Tropical &amp; Public Health Institute, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Juliano","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bina","family":"Srivastava","sequence":"additional","affiliation":[{"name":"National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia D. M.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA"},{"name":"Social &amp; Scientific Systems, Inc., Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Poole","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Anvikar","sequence":"additional","affiliation":[{"name":"National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Meshnick","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Valecha","sequence":"additional","affiliation":[{"name":"National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Mishra","sequence":"additional","affiliation":[{"name":"National Institute of Malaria Research, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"287","article-title":"Classification of antimalarial drugs in relation to different stages in the life-cycle of the parasite: commentary on a diagram","volume":"27","author":"Bruce-Chwatt LJ","year":"1962","unstructured":"Bruce-ChwattLJ. 1962. Classification of antimalarial drugs in relation to different stages in the life-cycle of the parasite: commentary on a diagram. Bull. World Health Organ. 27:287\u2013290.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-136"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050226"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/503051"},{"key":"e_1_3_2_6_2","first-page":"709","article-title":"The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin","volume":"107","author":"Chen PQ","year":"1994","unstructured":"ChenPQ LiGQ GuoXB HeKR FuYX FuLC SongYZ. 1994. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin. Med. J. 107:709\u2013711.","journal-title":"Chin. Med. J"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2003.01169.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/319689"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2008.08.011"},{"key":"e_1_3_2_10_2","first-page":"397","article-title":"Pharmacology of 8-aminoquinolines","volume":"59","author":"Grewal RS","year":"1981","unstructured":"GrewalRS. 1981. Pharmacology of 8-aminoquinolines. Bull. World Health Organ. 59:397\u2013406.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_2_11_2","first-page":"451","article-title":"The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum","volume":"24","author":"Burgess RW","year":"1961","unstructured":"BurgessRW BrayRS. 1961. The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. Bull. World Health Organ. 24:451\u2013456.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_2_12_2","first-page":"650","article-title":"The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia","volume":"24","author":"Gunders AE","year":"1961","unstructured":"GundersAE. 1961. The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia. Bull. World Health Organ. 24:650\u2013653.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-S1-S8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-137"},{"key":"e_1_3_2_15_2","first-page":"1","article-title":"Monitoring antimalarial resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010","volume":"91","author":"Mishra N","year":"2012","unstructured":"MishraN SinghJ SrivastavaB AroraU ShahNK GhoshS BhattR SharmaS DasM KumarA AnvikarA KaitholiaK GuptaR SonalG DhariwalA ValechaN. 2012. Monitoring antimalarial resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Bull. World Health Organ. 91:1\u201319.","journal-title":"Bull. World Health Organ"},{"key":"e_1_3_2_16_2","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. 2009. Methods for surveillance of antimalarial drug efficacy. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(02)90385-8"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00051-10"},{"key":"e_1_3_2_19_2","first-page":"349","article-title":"Current scenario of malaria in India","volume":"41","author":"Sharma VP","year":"1999","unstructured":"SharmaVP. 1999. Current scenario of malaria in India. Parassitologia 41:349\u2013353.","journal-title":"Parassitologia"},{"key":"e_1_3_2_20_2","first-page":"840","article-title":"Epidemiological status of malaria and scaling up of interventions in India","volume":"108","author":"Sonal GS","year":"2010","unstructured":"SonalGS ThakorHG JoshiC AroraP GuptaRKD DhariwalAC. 2010. Epidemiological status of malaria and scaling up of interventions in India. J. Indian Med. Assoc. 108:840\u2013843.","journal-title":"J. Indian Med. Assoc"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2307\/2533573"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.640"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2003.01093.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008492.pub2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70187-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001023"},{"key":"e_1_3_2_27_2","first-page":"307","article-title":"Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development","volume":"29","author":"V\u00e1squez AM","year":"2009","unstructured":"V\u00e1squezAM San\u00ednF AlvarezLG Tob\u00f3nA R\u00edosA BlairS. 2009. Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development. Biomedica 29:307\u2013319. (In Spanish.)","journal-title":"Biomedica"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis959"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1999.11813487"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1179\/000349804225003550"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-16"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01135-09"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2010.08.005"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-43"},{"key":"e_1_3_2_35_2","unstructured":"EziefulaA\nStaedkeS. 2011. Evaluation of the gametocytocidal efficacy and safety of primaquine in uncomplicated falciparum malaria in Uganda. NIH Clinical Trials Registry. http:\/\/clinicaltrials.gov\/show\/NCT01365598."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-424"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-418"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-159"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-281"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.76.470"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008410"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-2-200107170-00012"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2001.64.32"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70198-6"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00139-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00139-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:33:18Z","timestamp":1645482798000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00139-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1128\/AAC.00139-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.00139-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"2013-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}